Decreased expression of Bmal2 in patients with Parkinson's disease

Neuroscience Letters

Volumn 499, Issue 3, 2011, Pages 186-188

  Ding, Hui ^a   Liu, Shu ^a   Yuan, Yanpeng ^a   Lin, Qingling ^a   Chan, Piu ^a   Cai, Yanning ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bmal2; Circadian rhythm; Clock; Dec1; Parkinson's disease

Indexed keywords

BMAL2 PROTEIN; DEC1 PROTEIN; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LEUKOCYTE; MOLECULAR CLOCK; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ARNTL TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CLOCK PROTEINS; HUMANS; PARKINSON DISEASE; TUMOR SUPPRESSOR PROTEINS;

EID: 79960088546     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.058     Document Type: Article

References (19)

1. Bruguerolle B., Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 2002, 25:194-201.
2. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., Simon M.C., Takahashi J.S., Bradfield C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
3. Buysse D.J., Reynolds C.F., Monk T.H., Hoch C.C., Yeager A.L., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
4. Cai Y., Liu S., Southern R., Xu S., Chan P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol. 2010, 17:550-554.
5. Cermakian N., Whitmore D., Foulkes N.S., Sassone-Corsi P. Asynchronous oscillations of two zebrafish CLOCK partners reveal differential clock control and function. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4339-4344.
6. Dardente H., Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 2007, 24:195-213.
7. DeBruyne J.P., Weaver D.R., Reppert S.M. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat. Neurosci. 2007, 10:543-545.
8. Fahn S., Elton R.L. The members of the UPDRS Development Committee, United Parkinson_s Disease rating scale. Recent Development in Parkinson's Disease 1987, 153-163. Mac-Millan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne, A. Lieberman (Eds.).
9. Hogenesch J.B., Gu Y.Z., Moran S.M., Shimomura K., Radcliffe L.A., Takahashi J.S., Bradfield C.A. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J. Neurosci. 2000, 20:RC83.
10. Hung M.S., Avner P., Rogner U.C. Identification of the transcription factor ARNTL2 as a candidate gene for the type 1 diabetes locus Idd6. Hum. Mol. Genet. 2006, 15:2732-2742.
11. Kawamoto T., Noshiro M., Sato F., Maemura K., Takeda N., Nagai R., Iwata T., Fujimoto K., Furukawa M., Miyazaki K., Honma S., Honma K., Kato Y. A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. Biochem. Biophys. Res. Commun. 2004, 313:117-124.
12. Okano T., Sasaki M., Fukada Y. Cloning of mouse BMAL2 and its daily expression profile in the suprachiasmatic nucleus: a remarkable acceleration of Bmal2 sequence divergence after Bmal gene duplication. Neurosci. Lett. 2001, 300:111-114.
13. Sasaki M., Yoshitane H., Du N.H., Okano T., Fukada Y. Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription. J. Biol. Chem. 2009, 284:25149-25159.
14. Sato F., Kawamoto T., Fujimoto K., Noshiro M., Honda K.K., Honma S., Honma K., Kato Y. Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation. Interaction with BMAL1. Eur. J. Biochem. 2004, 271:4409-4419.
15. Schoenhard J.A., Smith L.H., Painter C.A., Eren M., Johnson C.H., Vaughan D.E. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J. Mol. Cell. Cardiol. 2003, 35:473-481.
16. Shi S., Hida A., McGuinness O.P., Wasserman D.H., Yamazaki S., Johnson C.H. Circadian clock gene Bmal1 is not essential; functional replacement with its paralog, Bmal2. Curr. Biol. 2010, 20:316-321.
17. Vitaterna M.H., Selby C.P., Todo T., Niwa H., Thompson C., Fruechte E.M., Hitomi K., Thresher R.J., Ishikawa T., Miyazaki J., Takahashi J.S., Sancar A. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12114-12119.
18. Willis G.L. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev. Neurosci. 2008, 19:245-316.
19. Zheng B., Albrecht U., Kaasik K., Sage M., Lu W., Vaishnav S., Li Q., Sun Z.S., Eichele G., Bradley A., Lee C.C. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001, 105:683-694.